Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YAZ in moderate acne vulgaris
NCT00651469Phase 3Completed
- Sponsor
- Bayer
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in acne vulgaris, sponsored by Bayer. Started Jan 2003; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00651469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651469.